HealthMore in Health→
Vinay Prasad Departs FDA Amid Regulatory Turmoil
Key Takeaways
- Vinay Prasad departing FDA's Center for Biologics Evaluation and Research
- Was key ally of Commissioner Makary's regulatory reform agenda
- Departure raises questions about continuity of FDA reform initiatives
DE
DT Editorial Team··3 min read·via statnews.com